Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to learn about the effect of Apollo (a vibrating wearable about the side of an Apple Watch) on fatigue, Raynaud symptoms, depression, quality of life, and disease symptoms in patients with systemic sclerosis. SSc patients frequently have fatigue as a characteristic feature of their disease and fatigue negatively impacts quality of life (Haythornthwaite 2003, Richards 2003, Suarez-Almazor 2007, Basta 2017). The prevalence of fatigue among SSc patients is 75%, with 61% ranking fatigue among their top three most distressing complaints. Fatigue is also associated with poor sleep quality, greater pain and depressive symptoms (Sandusky 2009). We hypothesize that treatment with Apollo over 1 month will improve fatigue. If successful, the Apollo technology will be the first treatment option for fatigue and Raynaud's in this population.

Clinical Trial Description

This is a study of the commercially available Apollo Neuro Wellness Device, which is not currently a medical device. The device offers a convenient novel non-invasive, non-habit-forming solution to improve performance and recovery under stress in children and adults by delivering gentle wave-like vibrations to the body that improve autonomic nervous system balance in real time (Siegle & Rabin et al., under review). Apollo vibrations activate touch receptors in the skin and are perceived as safety signals by the brain resulting in decreased stress, improved recovery, focus, and energy. A total of 30-40 patients will be enrolled and followed for 1 month, with baseline data collected before using Apollo and follow-up data collected after using the device. This clinical trial is open-label, meaning that all participants will receive Apollos and no placebos will be used. All participants will be allowed to continue underlying immunosuppressive and Raynaud therapy at stable doses during the trial. Since this is a pilot study, future larger controlled trials will be necessary to clearly demonstrate drug effectiveness. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT04854850
Study type Interventional
Source University of Pittsburgh
Contact Robyn T Domsic, MD
Phone 412-383-8000
Email [email protected]
Status Recruiting
Phase N/A
Start date July 7, 2020
Completion date June 30, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04531891 - Utility and Validity of a High-intensity, Intermittent Exercise Protocol N/A
Completed NCT02948283 - Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia Phase 1
Completed NCT03943212 - The Effect of Blood Flow Rate on Dialysis Recovery Time in Patients Undergoing Maintenance Hemodialysis N/A
Recruiting NCT04591574 - ABC - A Post Intensive Care Anaemia Management Trial N/A
Not yet recruiting NCT04497025 - Conventional Vestibular Training Versus Immersive Virtual Reality- Based Vestibular in Multiple Sclerosis N/A
Recruiting NCT04091789 - Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea Phase 2
Completed NCT02911649 - Reducing Sedentary Behaviour With Technology N/A
Completed NCT02321358 - Trial of a Behavior Change Intervention to Increase Aerobic and Resistance Exercise and Quality of Life in Older Prostate and Breast Cancer Survivors N/A
Completed NCT03216616 - Guided Self-Management Intervention Targeting Fatigue in Rheumatic Inflammatory Diseases N/A
Completed NCT01707095 - Bundling and Unbundling the Laparoscopic Electrosurgery Cord With the Camera Cord N/A
Terminated NCT01740154 - Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer N/A
Completed NCT01919853 - Treatment for Persistently Fatigued Cancer Survivors: A Randomized Controlled Trial With Biomarker Response Phase 2
Completed NCT01744678 - Fatigue Countermeasure Program in Operational Flight Controllers N/A
Not yet recruiting NCT01228006 - Study for Effectiveness Evaluation of Panax Ginseng, Vitamins and Minerals (Natugerin®) in Improvement of Stress and Fatigue Phase 3
Completed NCT01407770 - Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Completed NCT01444300 - Dalfampridine for Imbalance in Multiple Sclerosis Phase 2
Terminated NCT01572168 - Acupuncture for the Treatment of Cancer Related Fatigue Phase 2
Recruiting NCT01097317 - First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer Phase 2
Completed NCT00924651 - Exercise in Lessening Fatigue Caused by Cancer in Patients Undergoing Chemotherapy Phase 3
Completed NCT00997269 - Benefit of CoQ-10 in Patients on Statins N/A